Klinefelter Syndrome Therapeutics Market, By Age Group (Below 16, 17 – 30 Years, 31 – 50 Years, 51 Years & Above), By Type of Treatment (Testosterone Replacement Therapy, Fertility Treatment (Surgeries, Hormone Treatments, Others)), By Form (Oral, Patches (Transdermal, Mouth), Gels, Injections, Pellets) - Global Industry Insights, Trends and Forecast (2017 - 2025)

Created On: Aug-2018
Report ID: IR186
Format: PDF

Klinefelter Syndrome Therapeutics Market: Introduction

Klinefelter Syndrome Therapeutics Market Size is predicted to grow over notable CAGR over the forecast period, owing to increasing infertility cases, hormone disorders, especially among the male population.

Klinefelter syndrome is a common genetic chromosomal condition, in which a male is usually born with an additional copy of X chromosome. This health disorder only affects males, and is highly undiagnosed. Around one in every 650 males have the chance to get affected.

Klinefelter Syndrome Therapeutics Market: Market Dynamics

Klinefelter syndrome is a major chromosomal condition which affects cognitive and physical development of males. The symptoms vary among all individuals who are affected. Fertility disorder cases among the male population is increasing significantly from the past few years, which will primarily drive the market. The symptoms will be developed among males among all age groups. This disease is majorly observed among new-born males. According to stats by the National Institute of Health (NIH), one person in 500 to 1,000 new born males are affected by Klinefelter syndrome.

According to the researchers at the NIH, the Klinefelter syndrome is highly underdiagnosed, due to its unidentifiable symptoms and signs among males. The signs of this condition differ and overlap with symptoms caused by other health disorders. Due to this, various organizations functioning in the Healthcare sector such as the NIH and FDA are increasing their awareness campaigns regarding this health disorder, by stressing the parents to conduct all kinds of health check-ups to identify this disease for their new-born baby. This disease, if detected at an early stage, can be prevented from development. Moreover, the awareness among the population is also increasing significantly from the past few years, which will act as another significant factor favoring the growth of this market.

Klinefelter syndrome therapeutics market size might be restrained by the lack of awareness among the population in the developing nations of Asia Pacific, Europe, Africa and Middle East regions. This market can further be restrained by the shortage of treatment facilities in these economies.

Klinefelter Syndrome Therapeutics Market Share: by Type of Treatment

By type of treatment, the Klinefelter therapeutics market has been segmented into testosterone replacement therapy, fertility treatment, and others. Fertility treatment segment is further segmented into surgeries, hormone treatments, etc. Testosterone replacement is the most common treatment method preferred by majority of the population of adult age groups (17 years to 50 years).

Klinefelter Syndrome Therapeutics Market: by Form

Based on form, the global Klinefelter therapeutics market share has been segmented into oral, patches, gels, injections, and pellets. Patches are further segmented into transdermal and mouth (buccal). Injection-based Klinefelter therapeutics market is predicted to have the prime market share, owing to its high preference for males among the new born to 14 years age group.

Patches-based Klinefelter therapeutics market is expected to grow at a prime CAGR throughout the forecast period. This is majorly due to increasing product preference among people of age groups 17 – 30 years, 31 – 50 years, and 51 & above.

Klinefelter Syndrome Therapeutics Market Share: by Region

North America Klinefelter syndrome therapeutics market is predicted to dominate the global market over the entire forecast period. This is majorly due to high presence of testosterone drug manufacturers, coupled with increased awareness among the population of this region. Moreover, huge presence of treatment centers for this disorder will further enhance the market share over the forecast period.

Asia Pacific market is predicted to grow at a higher CAGR, owing to the increase awareness of people regarding this disorder. Additionally, this market will be driven by the increasing testosterone manufacturing in the developing countries of this region such as India and China.

Klinefelter Syndrome Therapeutics Market: Competitive Landscape

Some of the key players in the global klinefelter syndrome therapeutics market include Lupin Pharmaceuticals, Allergan plc, AbbVie, Inc., Endo Pharmaceuticals, Inc., Kyowa Kirin International plc, Eli Lilly and Company, Pfizer, Inc., and Mylan N.V. and among several others.

Major global pharmaceutical companies are working towards the development of various testosterone drugs, which will further help to enhance their respective market share. For instance, in February 2016, Lupin Pharmaceuticals, Inc. launched a testosterone topical solution in the U.S. for males, who are suffering from hormone deficiencies.

Moreover, several global pharmaceutical companies got their approval for testosterone drugs the U.S. FDA, and other healthcare organizations, which will help them to develop more variants for this drug. Currently, majority of these players are into the production and distribution of testosterone drug in the form of patches, injections, oral form, etc.

Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Reach Out to us